Today's News | Note: News feeds may no longer be available for the articles on this page.

Impax sued by Genzyme over dialysis drug 2:17 PM 4/6/2009
Bizjournals.com - Charlotte,NC,USA
Generic drugmaker Impax Laboratories Inc has been sued by Genzyme Corp over the copy of Renvela (sevelamer) to control levels of serum phosphorus in people undergoing dialysis treatment for kidney failure. ...

Bristol wins Abilify extension, sees profit boost 5:17 AM 4/6/2009
Reuters - USA
Bristol-Myers Squibb Co will sell its Abilify schizophrenia drug about 29 months longer than expected. The company's $5.6 billion-a-year Plavix blood clot preventer gets hit with generic competition in mid-2012. ...

FDA wants more data on Astra's Symbicort for kids 3:13 AM 4/6/2009
Reuters - UK
AstraZeneca Plc faces a delay in marketing its asthma drug Symbicort to young children in the US. The US FDA wants to review additional data. ...

Shire closing Owings Mills plant to focus on new drug deals 6:19 AM 4/4/2009
Bizjournals.com - Charlotte,NC,USA
Shire Pharmaceuticals Group PLC wants to reduce manufacturing so that it can invest in small drug companies and licensing deals. ...

Gilead shares rise on blood pressure drug study 12:36 PM 4/3/2009
Forbes - NY,USA
Gilead Sciences Inc said its high blood pressure drug candidate darusentan met key goals in a late stage clinical trial. ...

Sun Pharmaceutical Extends Tender Offer for Taro 10:23 AM 4/3/2009
RTT News - Williamsville,NY,USA
Sun Pharmaceutical Industries Ltd said its subsidiary Alkaloida Chemical Company Exclusive Group Ltd extended its tender offer for Taro Pharmaceutical Industries Ltd to April 17, 2009. ...

Pfizer moves arthritis, pain drugs to late trials 2:55 PM 4/2/2009
Reuters - USA
Recently moved into Phase III studies is JAK inhibitor (CP-690,550). It's the first disease-modifying pill for rheumatoid arthritis in the last decade. Also entering Phase III is the monoclonal antibody tanezumab that in earlier trials reduced knee pain in patients with osteoarthritis. ...

Pfizer Halts a Study of Sutent as Breast-Cancer Drug 9:18 AM 4/2/2009
BusinessWeek - USA
Pfizer Inc stopped a late-stage study of the cancer drug Sutent (sunitinib) to treat a form of advanced breast cancer. The company will continue examining the drug in other trials. ...

Lannett balks at FDA order to remove drugs 5:34 AM 4/2/2009
Philadelphia Inquirer - Philadelphia,PA,USA
The US FDA gave Lannett and eight other companies 15 days to stop making and selling prescription versions of potent morphine, hydromorphone, and oxycodone. Some of these drugs were marketed before the FDA approval process existed and may not be safe or effective. ...

Long-acting Byetta superior in diabetes trial 4:22 PM 4/1/2009
Reuters - USA
The experimental long-acting version of diabetes drug Byetta (exenatide) demonstrated superior blood sugar control and weight loss. It's being developed by Amylin Pharmaceuticals Inc and Eli Lilly. ...

Caraco Pharma recalls heart drug Digoxin 4:58 PM 3/31/2009
Reuters - USA
Caraco Pharmaceutical Laboratories Ltd is recalling batches of the heart drug Digoxin distributed prior to March 31. The tablets could vary in size and dosage levels. ...

US panel sees brain cancer benefit with Roche drug 3:39 PM 3/31/2009
Reuters - USA
Roche Holding's Avastin shows enough promise in treating patients with a certain brain cancer to be considered for quick approval. The drug is made by recently acquired Genentech unit and is already used to treat lung, colon, and breast cancers. ...

Arena Falls 28% on Drug Trial 9:02 AM 3/31/2009
Wall Street Journal - USA
Arena Pharmaceuticals Inc shares fell after its trial for an obesity treatment met its primary goal with one result on weight loss missing the FDA guideline. ...

US FDA seeks input on Novo drug heart, tumor risk 8:12 AM 3/31/2009
Reuters - USA
An advisory panel will assess heart risks from Novo Nordisk's proposed diabetes drug liraglutide. Some comparisons with a placebo did not favor liraglutide, depending on the analysis method used. ...

Acorda says FDA refuses to file NDA for MS drug 7:11 AM 3/31/2009
Reuters - USA
The US FDA refused to file a new drug application for its multiple sclerosis drug Fampridine-SR citing "format issues". ...

<- Day Earlier | Today's News